Ben Hwang is the chairman and CEO of Profusa, a San Francisco-based biotechnology company, that is developing micro sensors to monitor body chemistry. A former management consultant, Ben earned his MA and PhD in biology from the Johns Hopkins University. He has worked in a variety of biotech roles and is dedicated to developing technology that promotes good health and longevity. Profusa (@profusaInc) is on a mission is to make the inner workings of our bodies more accessible. The goal, using micro sensors, is to gather information about internal biochemical changes, in real time. The 3 to 5 mm long sensors are designed to be compatible with the body’s tissues for long-term monitoring. They collect data, transmitted to external devices, providing a stream of information for long-term health and wellness. Ben Hwang spoke to LLAMA host, Peter Bowes, at TEDMED in California.